Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors Meeting Abstract


Authors: Beryozkina, A.; Nichols, G. L.; Reckner, M.; Vassilev, L. T.; Rueger, R.; Jukofsky, L.; Middleton, S.; Andreeff, M.; Padmanabhan, S.; Strair, R.; Delioukina, M. L.; Maslak, P. G.; Hillmen, P.; Kurzrock, R.; Gore, L.; Patnaik, A.; Maki, R. G.; Schwartz, G. K.; Wagner, A. J.; Zhi, J.
Abstract Title: Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880301468
DOI: 10.1200/jco.2011.29.15_suppl.3039
PROVIDER: wos
Notes: Meeting Abstract: 3039 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Robert Maki
    238 Maki
  3. Peter Maslak
    197 Maslak